Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Neutralizing antibody response after intradermal rabies vaccination in hemodialysis patients.

Tanisaro T, Tantawichien T, Tiranathanagul K, Susantitaphong P, Chirananthavat T, Praditpornsilpa K, Sitprija V, Eiam-Ong S.

Vaccine. 2010 Mar 11;28(12):2385-7. doi: 10.1016/j.vaccine.2010.01.003. Epub 2010 Jan 17.

PMID:
20085837
2.

Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.

Wongsaroj P, Udomchaisakul P, Tepsumethanon S, Khawplod P, Tantawichien T.

Vaccine. 2013 Mar 25;31(13):1748-51. doi: 10.1016/j.vaccine.2013.01.035. Epub 2013 Jan 29.

PMID:
23370149
3.

Postexposure rabies prophylaxis completed in 1 week: preliminary study.

Shantavasinkul P, Tantawichien T, Wilde H, Sawangvaree A, Kumchat A, Ruksaket N, Lohsoonthorn V, Khawplod P, Tantawichien T.

Clin Infect Dis. 2010 Jan 1;50(1):56-60. doi: 10.1086/649211.

PMID:
19995217
4.

Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.

Tantawichien T, Benjavongkulchai M, Limsuwan K, Khawplod P, Kaewchompoo W, Chomchey P, Sitprija V.

Clin Infect Dis. 1999 May;28(5):1100-3.

PMID:
10452642
5.

Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.

Madhusudana SN, Sanjay TV, Mahendra BJ, Suja MS.

Int J Infect Dis. 2004 May;8(3):175-9.

6.

Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.

Tantawichien T, Sibunruang S, Tantawichien T, Angsanakul J, Benjavongkulchai M, Limsuwan K, Udomchaisakul P, Khomvilai S, Sitprija V.

Expert Rev Vaccines. 2014 Dec;13(12):1593-601. doi: 10.1586/14760584.2014.971764. Epub 2014 Oct 15.

PMID:
25315021
7.

Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis.

Wang LY, Sun MP, Zhang XC, Suo LD, Xu RH, Zou YJ, Zuo LB, Qi H.

Vaccine. 2011 Mar 24;29(15):2679-81. doi: 10.1016/j.vaccine.2011.01.053. Epub 2011 Feb 3.

PMID:
21296694
8.

Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.

Sirikwin S, Likanonsakul S, Waradejwinyoo S, Pattamadilok S, Kumperasart S, Chaovavanich A, Manatsathit S, Malerczyk C, Wasi C.

Vaccine. 2009 Jul 9;27(32):4350-4. doi: 10.1016/j.vaccine.2009.03.027. Epub 2009 Apr 3.

PMID:
19487057
9.

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.

Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C.

Bull World Health Organ. 2000;78(5):693-8.

10.

Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine.

Sampath G, Madhusudana SN, Sudarshan MK, Ashwathnarayana DH, Mahendra BJ, Ullas TP, Mohan K, Madhusudhan SK, Ravish HS.

Vaccine. 2010 May 28;28(24):4086-90. doi: 10.1016/j.vaccine.2010.03.064. Epub 2010 Apr 18.

PMID:
20403351
11.

A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).

Ashwathnarayana DH, Madhusudana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HH, Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, Shamanna M.

Vaccine. 2009 Dec 10;28(1):148-51. doi: 10.1016/j.vaccine.2009.09.090. Epub 2009 Oct 8. Erratum in: Vaccine. 2010 Mar 16;28(13):2575.

PMID:
19818720
12.

[Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].

Baysal B, Tosun S, Ozdemir M, Do─čan M.

Mikrobiyol Bul. 2009 Jan;43(1):127-31. Turkish.

PMID:
19334389
13.

A pilot study on intradermal vaccination of Japanese rabies vaccine for pre-exposure immunization.

Shiota S, Khawplod P, Ahmed K, Mifune K, Nishizono A.

Vaccine. 2008 Nov 25;26(50):6441-4. doi: 10.1016/j.vaccine.2008.08.068. Epub 2008 Sep 18.

PMID:
18804510
15.

Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination.

Jaijaroensup W, Limusanno S, Khawplod P, Serikul K, Chomchay P, Kaewchomphoo W, Tantawichien T, Wilde H.

J Travel Med. 1999 Dec;6(4):234-7.

16.
18.

Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.

Roukens AH, Vossen AC, van Dissel JT, Visser LG.

Vaccine. 2008 Jun 25;26(27-28):3438-42. doi: 10.1016/j.vaccine.2008.04.033. Epub 2008 May 5.

PMID:
18511158
19.

Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults.

Laurent PE, Bourhy H, Fantino M, Alchas P, Mikszta JA.

Vaccine. 2010 Aug 16;28(36):5850-6. doi: 10.1016/j.vaccine.2010.06.062. Epub 2010 Jun 30.

PMID:
20600481
20.

Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.

Sudarshan MK, Narayana DH, Madhusudana SN, Holla R, Ashwin BY, Gangaboraiah B, Ravish HS.

Hum Vaccin Immunother. 2012 Aug;8(8):1077-81. doi: 10.4161/hv.20471. Epub 2012 Aug 1.

Supplemental Content

Support Center